Metabolic Surgery for Diabetes — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — BMI ≥30 with uncontrolled diabetes on maximal medical therapy
Current guidelines (IFSO, ADS/ANZMOSS) support metabolic/bariatric surgery for patients with T2DM and BMI ≥30 (or ≥27.5 in Asian populations) who have inadequately controlled diabetes despite optimised medical therapy. The STAMPEDE trial showed sustained diabetes remission at 5 years post-surgery. In Australia, PBS and MBS criteria support surgical eligibility at these thresholds. Surgery achieves superior glycaemic control, weight loss, and cardiovascular risk reduction compared to medical therapy alone.
Reference: ADS/ANZMOSS – 2024 – Metabolic Surgery Position Statement; eTG – 2025 – Endocrinology